Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase I Human Analytics (HALO) Study
Sponsor: HALO Diagnostics
Summary
Discover, optimize, standardize, and validate clinical-trial measures and biomarkers used to diagnose and differentiate cardiovascular, oncologic, neurologic, and other diseases and disorders. Specifically, our research study endeavors to improve disease and disorder diagnosis to the earliest clinical states, in preclinical states, and to develop ensemble multivariate biomarker risk scores leading to cardiovascular, oncologic, neurologic, and other diseases and disorders. Additionally, the study aims to: * Evaluate data analysis techniques to improve diagnostic accuracy and reduce time to diagnosis. * Evaluate data analysis techniques to improve risk stratification for participants through machine learning algorithms. * Direct participants to relevant and applicable clinical trials.
Official title: This is a Human Analytics Longitudinal Observational (HALO) Study. A Phase I Study to Analyze All Available Biomarkers and Determinants of Health to Increase Diagnostic Accuracy While Reducing the Time to Diagnosis of Disease.
Key Details
Gender
MALE
Age Range
45 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2022-03-16
Completion Date
2037-03
Last Updated
2022-10-14
Healthy Volunteers
No
Interventions
no interventions will be performed (observational)
Not applicable. (no interventions will be performed with this observational study
Locations (1)
Desert Medical Imaging
Indian Wells, California, United States